Rep. Tom Price had no idea his financial manager had purchased stock in a medical device company shortly before he introduced legislation that would have helped the company last year, President-elect Trump’s team said late Monday evening.

“Any effort to connect the introduction of bipartisan legislation by Dr. Price to any campaign contribution is demonstrably false,” Phil Blando, a Trump transition spokesman, said in a statement. “The only pattern we see emerging is that Senate Democrats and their liberal media allies cannot abide the notion that Dr. Tom Price is uniquely qualified to lead HHS and will stop at nothing to smear his reputation.”